Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.006 Å; R factor = 0.055; wR factor = 0.139; data-to-parameter ratio = 14.8.
The title compound, [Cu(NCS) 2 (C 20 H 21 N 3 )]Á0.5CH 2 Cl 2 , crystallized with two independent complex molecules (A and B) in the asymmetric unit, accompanied by one dichloromethane solvent molecule. Each Cu II atom has a square-pyramidal geometry, being coordinated by five N atoms, three from the (4-methylbenzyl)bis(pyridin-2-ylmethyl)amine ligand and two from the thiocyanate ligands. In the crystal, the B molecules are linked via C-HÁ Á ÁS interactions, forming chains propagating along [100] .
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Figure 1
The molecular structure of the two independent molecules (A and B) of the title compound, with the atomic numbering.
Displacement ellipsoids are drawn at the 30% probability level [the H atoms have been omitted for clarity].
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